Gong Zhenyu (Selective Translation), Gong Xunliang (Review). Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices—United States, 2025J. Disease Surveillance. DOI: 10.3784/jbjc.202601140025
|
Citation:
|
Gong Zhenyu (Selective Translation), Gong Xunliang (Review). Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices—United States, 2025J. Disease Surveillance. DOI: 10.3784/jbjc.202601140025
|
Gong Zhenyu (Selective Translation), Gong Xunliang (Review). Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices—United States, 2025J. Disease Surveillance. DOI: 10.3784/jbjc.202601140025
|
Citation:
|
Gong Zhenyu (Selective Translation), Gong Xunliang (Review). Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices—United States, 2025J. Disease Surveillance. DOI: 10.3784/jbjc.202601140025
|
Home
DownLoad: